Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

CVR Medical : Adds Two Wireless CSS Devices to Methodist Hospital – Expanding Clinical Substantiation Data for FDA Submission

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/13/2018 | 02:41pm CEST

VANCOUVER, BC / February 13, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) ('CVR Medical') announces placement of two additional wireless Carotid Stenotic Scan (CSS) devices into clinical trials at historic Methodist Hospital, part of the Thomas Jefferson University Hospital System. This deployment will be combined with the three wireless CSS devices already in use across the Thomas Jefferson University Hospital footprint. This critical milestone will assist in increasing the volume of clinical substantiation data to be used in the upcoming FDA submission to acquire market clearance.

The historic Methodist Hospital campus is located in the heart of south Philadelphia, having provided care since its doors opened in 1892. Over a century later, it now stands as a landmark of the Philadelphia landscape, boasting a bed count of over two hundred. In 1996, Methodist Hospital became a division of Thomas Jefferson University Hospital.

'When entering Methodist Hospital one cannot help but feel as though they are walking into a part of history,' states CVR COO Tony Robinson. 'From its inception in the late 1800's, to the support of world war II troops, to the renowned nursing school once located on the premise; I like to think we are adding to this line of accomplishment in bringing the trial to the Methodist site. I hope looking back, the CSS is another feather in the hat of the historic locale.'

For additional information on the organization, leadership, and current news, please visit the company's website www.CVRMed.com.

About CVR Medical

CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the 'Joint Venture'). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.

For further information contact:

Brisco Capital Partners Corp.
Scott Koyich, President
Telephone: (403) 262-9888

This press release contains forward-looking information that involves various risks and uncertainties regarding future events related to the Joint Venture and the proposed Financing. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements and are not guarantees of future performance of the Company. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. These forward-looking statements reflect management's current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) a downturn in general economic conditions in North America and internationally, (2) the inherent uncertainties and speculative nature associated with commercialization of technology and the practice of medicine, (3) a change in health regulations, (4) any number of events or causes which may delay or cease commercialization and development of the Joint Venture, (5) the risk that the Company or the Joint Venture does not execute its business plan, (6) inability to retain key employees, (7) inability to finance operations and growth, and (8) other factors beyond the Company's control. These forward-looking statements are made as of the date of this news release and, except as required by law, the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.

THE TSX VENTURE EXCHANGE INC. HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS PRESS RELEASE. NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CVR Medical Corp. published this content on 13 February 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 13 February 2018 13:40:07 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
09:47pSAMSUNG ELECTRONICS : GPEL launches Strongest tempered glass screen protector for Galaxy Note 9 – includes special Privacy version
AQ
09:46pBIOTOSCANA INVESTMENTS : 1H18 Fact Sheet Click here
PU
09:46p24th Annual Fall Life Settlement Conference to Explore Industry’s “World of Opportunities” from October 21st-23rd in Orlando
BU
09:45pROYAL DUTCH SHELL : Adair County man convicted of fraud
AQ
09:45pHYUNDAI MOTOR : Patent Issued for Acceleration Sensor And Manufacturing Method (USPTO 10,041,969)
AQ
09:44pNOVARTIS : Patent Issued for Yeast Display Systems (USPTO 10,041,064)
AQ
09:44pSAMSUNG ELECTRONICS : Researchers Submit Patent Application, "Device And Method Of Recognizing Iris", for Approval (USPTO 20180218213)
AQ
09:44pCLIC Technology, Inc. Appoints New PCAOB Auditor
AQ
09:44pEES Announces Return to Profitability in Second Quarter 2018
PR
09:44pBragar Eagel & Squire, P.C. is Investigating the Board of Directors of KMG Chemicals, Inc. (KMG) on Behalf of Stockholders and Encourages Investors to Contact the Firm
GL
Latest news "Companies"
Advertisement